CD274 and acral lentiginous melanoma: Median DOR was 8.8 months (range, 4.1–13.8+) in patients with PD-L1–positive acral melanoma and NR (range, 19.4+ to 37.4+ months) in patients with PD-L1–negative acral melanoma (Table 3).